Search

everythinglearnresearchcommunity

for

Search:↓

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Zinc pyrithione dissolves quickly on the skin and in hair follicles, especially in smaller particles.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

JAK inhibitors offer new hope for treating severe alopecia areata.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Erlotinib can cause hair loss and texture changes.

A new compound shows promise as a topical treatment for hair loss.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.